Manufacturing News and Research

RSS

Manufacturing is the production of products across all industries, on a large-scale, using machinery.

New Life MicroFab Division launched to provide micro-fabrication services

Life BioScience, Inc. has launched a new Life MicroFab™ Division that provides a broad range of micro-fabrication services for devices made in APEX Glass, APEX Ceramic, Silicon, Pyrex, SOI, Kapton and other standard materials used in the semiconductor manufacturing process.

8 Apr 2010

Avid Radiopharmaceuticals, PETNET Solutions collaborate in manufacture of Florbetapir F 18

Avid Radiopharmaceuticals, Inc. and PETNET Solutions, Inc., a wholly-owned subsidiary of Siemens Medical Solutions, USA, Inc., marked the first dose shipped from a PETNET Solutions manufacturing facility as part of its collaboration with Avid on Florbetapir F 18 (18F-AV-45 or Florbetapir), Avid's molecular imaging agent for positron emission tomography (PET) imaging of β-amyloid deposits in the brain, a key pathological component of Alzheimer's disease.

8 Apr 2010

Sigma-Aldrich, HSI sign distribution agreement for patented stable isotope labeled synthetic reagents

Sigma-Aldrich® announced today that it has signed an agreement with New Mexico Highlands University through its licensee, Highlands Stable Isotope Corp., to exclusively distribute a novel set of patented stable isotope labeled synthetic reagents.

7 Apr 2010

AbleNet adds Madentec's entire line of assistive technology solutions to product portfolio

AbleNet, Inc. announces the agreement with Madentec Limited of Edmonton, Alberta, Canada for the exclusive global rights to manufacture and sell their entire line of assistive technology solutions. This adds a broad portfolio of proven devices to the AbleNet computer access products. Madentec will continue to own the products and provide engineering development support, which has been their core strength.

7 Apr 2010

Lumenis' 2009 revenues down 12% to $226.1M

Lumenis Ltd., a global leader in developing, manufacturing and distributing a broad range of high-end medical lasers and sophisticated energy delivery equipment for surgical, ophthalmic and aesthetic applications, today announced its financial results for the year ended December 31, 2009 and that it has filed its 2009 annual report on Form 20-F with the U.S. Securities and Exchange Commission.

From Lumenis Inc. 7 Apr 2010

Sinovac Biotech's fourth-quarter sales increase 194%

Sinovac Biotech Ltd., a leading China-based vaccine manufacturer, announced today its unaudited financial results for the three-month and preliminary twelve-month periods ended December 31, 2009.

6 Apr 2010

CAIRE plans to close liquid oxygen therapy manufacturing operations in Plainfield: Chart Industries

Chart Industries, Inc., a leading independent global manufacturer of highly engineered equipment used in the production, storage and end-use of hydrocarbon and industrial gases, today announced that CAIRE, which operates under Chart's BioMedical segment, plans to close its liquid oxygen therapy manufacturing operations in Plainfield, Indiana and relocate the manufacturing and customer service operations to a facility close to existing operations in Canton, Georgia where it manufactures the same product line.

From CAIRE Inc 6 Apr 2010

$296 million guilty plea from Boston Scientific in relation to Guidant defibrillator case

The implantable cardioverter defibrillator (ICD) is a life saving battery operated device much like a pacemaker that is placed near the heart in a minor surgical procedure. This device detects abnormal heart rates and rhythms in the patient and delivers an electric shock to make the heart beat normally again. These save millions of people in the US and all over the world from sudden death.

6 Apr 2010

SAFC announces opening of $30M expansion to Madison Manufacturing facility in Verona, Wisconsin

SAFC®, a member of the Sigma-Aldrich® Group, today announced the opening of a $30 million expansion to its Madison Manufacturing facility in Verona, Wisconsin.

6 Apr 2010

TachoSil blood-clotting patch receives FDA approval for cardiovascular surgery

The U.S. Food and Drug Administration today approved TachoSil, the first absorbable fibrin sealant patch for use in cardiovascular surgery to prevent mild and moderate bleeding from small blood vessels, when standard surgical techniques are ineffective or impractical.

6 Apr 2010

Humana adopts radiology benefit management programs to reduce unnecessary radiation exposure

Humana Inc. has reduced unnecessary radiation exposure for its members by the equivalent of more than five million chest x-rays since 2004, demonstrating how health benefits companies can lead the way in improving the quality and safety of health.

6 Apr 2010

Unilife's Unitract 1mL Insulin Syringes receive 510(k) market clearance

Unilife Corporation today announced it has received from the U.S. Food and Drug Administration 510(k) market clearance for the Unitract™ 1mL Insulin Syringes assembled at its Lewisberry, PA manufacturing facility.

6 Apr 2010

Isis Pharmaceuticals to lease new 176,000 square foot research facility from BioMed Realty Trust

BioMed Realty Trust, Inc. today announced that it has expanded its strategic real estate partnership with Isis Pharmaceuticals, Inc. BioMed extended its lease for Isis' current facility at Faraday Avenue in Carlsbad, California and added a lease for a new build-to-suit project, increasing the total leased space to approximately 204,700 square feet.

5 Apr 2010

Halozyme Therapeutics secures multiple commercial supply agreements for rHuPH20

Halozyme Therapeutics, Inc., a biopharmaceutical company developing and commercializing products targeting the extracellular matrix, today announced the execution of multiple commercial supply agreements with its existing manufacturing partners. Halozyme amended an existing commercial supply agreement with Avid Bioservices, Inc., entered into a new commercial supply agreement with Avid and entered into a new commercial supply agreement with Cook Pharmica LLC.

5 Apr 2010

Patheon to commence private placement of $280M senior secured notes due 2017

Patheon Inc., a global provider of drug development and manufacturing services to the international pharmaceutical industry, announced today that it intends to commence a private placement of $280 million in aggregate principal amount of senior secured notes due 2017. The net proceeds of the Offering will be used to repay all of the outstanding indebtedness under the company's existing senior secured term loan and asset-based revolving credit facility, to repay certain other indebtedness and to pay related fees and expenses.

5 Apr 2010

China's SFDA finds certain batches of Jiangsu Yanshen's human use rabies vaccine substandard

Simcere Pharmaceutical Group, a leading pharmaceutical company specializing in the development, manufacturing, and marketing of branded generic and proprietary pharmaceuticals in China, today reported that China's State Food and Drug Administration ("SFDA") issued a statement on its investigation into the human use rabies vaccine manufactured by Jiangsu Yanshen Biological Technology Stock Co., Ltd.. Simcere obtained a controlling stake in Jiangsu Yanshen on October 24, 2009.

5 Apr 2010

New report assesses optimal future for REMS

Two years after the Food and Drug Administration Amendments Act of 2007 gave FDA new powers to require Risk Evaluation and Mitigation Strategies for higher risk drugs and biologics, a new report concludes that an optimal future for REMS is possible if the agency adopts a systems approach when designing REMS programs and takes advantage of new technologies -- from electronic medical records to genetic testing -- that are changing the way medicine is practiced.

5 Apr 2010

SE5-OH with Natural S-equol supplement appears to be safe for pre- and post-menopausal women

Healthy pre-and post-menopausal Japanese women who took a supplement of SE5-OH containing Natural S-equol, a novel soy germ-based ingredient under development for the management of menopausal symptoms, had measures of reproductive hormones that stayed within normal limits throughout the study.

3 Apr 2010

Cancer Prevention Coalition's statement on new nominated NCI Director

Last Wednesday, the White House nominated Nobel Laureate Harold Varmus as Director of the National Cancer Institute.

3 Apr 2010

No doughnut hole in global mail-order pharmacy

Thanks to the Patient Protection and Affordable Care Act signed into law by President Obama on March 23, 2010, Medicare enrollees who enter the dreaded "doughnut hole" -- the Medicare Part D coverage gap that has made seniors responsible for all their drug costs between $2,830 and $6,440 -- will save $250 in 2010. But Betterthanmedicare.com is already saving seniors thousands of dollars, because the global mail-order pharmacy has no doughnut hole.

2 Apr 2010

Manufacturing News and Research

Further Reading

New Life MicroFab Division launched to provide micro-fabrication services

Avid Radiopharmaceuticals, PETNET Solutions collaborate in manufacture of Florbetapir F 18

Sigma-Aldrich, HSI sign distribution agreement for patented stable isotope labeled synthetic reagents

AbleNet adds Madentec's entire line of assistive technology solutions to product portfolio

Lumenis' 2009 revenues down 12% to $226.1M

Sinovac Biotech's fourth-quarter sales increase 194%

CAIRE plans to close liquid oxygen therapy manufacturing operations in Plainfield: Chart Industries

$296 million guilty plea from Boston Scientific in relation to Guidant defibrillator case

SAFC announces opening of $30M expansion to Madison Manufacturing facility in Verona, Wisconsin

TachoSil blood-clotting patch receives FDA approval for cardiovascular surgery

Humana adopts radiology benefit management programs to reduce unnecessary radiation exposure

Unilife's Unitract 1mL Insulin Syringes receive 510(k) market clearance

Isis Pharmaceuticals to lease new 176,000 square foot research facility from BioMed Realty Trust

Halozyme Therapeutics secures multiple commercial supply agreements for rHuPH20

Patheon to commence private placement of $280M senior secured notes due 2017

China's SFDA finds certain batches of Jiangsu Yanshen's human use rabies vaccine substandard

New report assesses optimal future for REMS

SE5-OH with Natural S-equol supplement appears to be safe for pre- and post-menopausal women

Cancer Prevention Coalition's statement on new nominated NCI Director

No doughnut hole in global mail-order pharmacy

Achieving and maintaining ISO 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest Life Science News